Understanding your personal clinical profileincluding genetic predispositions that may influence how your body responds to GLP-1 pathway medicationscan support a more meaningful conversation with your provider about whether semaglutide is right for you, which formulation to choose, and what dosing strategy makes sense
The drug is currently under regulatory review in the U.S., with a decision expected by April 10, 2026
In other words, pills can take longer to raise B12 levels, so if you need a quick boost, injections are the better choice
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for managing type 2 diabetes and, at higher doses, for chronic weight management in adults with obesity or overweight with weight-related comorbidities
Potter said that before she started her treatment, she asked one of her husband's friends with a medical background for guidance
severe abdominal pain, vomiting, or jaundice require urgent medical review